Soy isoflavones' osteoprotective role in postmenopausal women: Mechanism of action

Journal of Nutritional Biochemistry

Volumn 13, Issue 3, 2002, Pages 130-137

  Arjmandi, Bahram H ^a   Smith, Brenda J ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Isoflavones; Menopause; Osteoporosis; Selective estrogen receptor modulators (SERMs); Soy

Indexed keywords

ISOFLAVONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOYBEAN PROTEIN;

ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; DRUG MECHANISM; HORMONE DEFICIENCY; HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE;

ANIMALIA;

EID: 0036124597     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(02)00172-9     Document Type: Review

References (61)

1. Bone loss and aging
2. The pathogenesis of osteoporosis
3. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women
4. Effects of recombinant human growth hormone and insulin-like growth factor-I, with and without 17β-estradiol, on bone and mineral homeostasis of aged ovariectomized rats
5. Estrogens in the prevention of osteoporosis in postmenopausal women
6. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis
7. Hormonal chemoprevention of cancer in women
8. Estrogen replacement therapy: Indications and complications
9. Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to resolution of the controversy
10. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
11. Correlates of postmenopausal estrogen use and trends through the 1980s in two Southeastern New England communities
12. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women
13. Estrogens, the menopause, and osteoporosis
14. Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial FIT Research Group
15. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
16. Raloxifene and estrogen: Comparative bone-remodeling kinetics
17. Selective estrogen receptor modulators: Clinical spectrum
18. Selective estrogen receptor modulators: An alternative to hormone replacement therapy
19. Soy isoflavones - Benefits and risks from nature's selective estrogen receptor modulators (SERMs)
20. Phytoestrogens: The "natural" selective estrogen receptor modulators
21. Oral contraceptives in ancient and medieval times
22. Commonly occurring plant flavonoids have estrogenic activity
23. Nonsteroidal estrogens of dietary origin: Possible roles in hormone-dependent disease
24. Soya - A dietary source of the non-steroidal oestrogen equol in men and animals
25. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women
26. Long term intake of soy protein improves blood lipid profiles and increases mononuclear cell low density lipoprotein messenger RNA in hypersholesterolemic, postmenopausal women
27. Legumes and soybeans: Overview of their nutritional profiles and health effects
28. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
29. Effects of dietary phytoestrogens in postmenopausal women
30. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women
31. Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density
32. Soy intake and the maintenances of peak bone mass in Hong Kong Chinese women
33. Effects of s and 2000oy protein on bone metabolism in postmenopausal Japanese women
34. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women
35. Dietary soy supplementation reduces LDL-oxidation and bone turnover in healthy postmenopausal women
36. Isoflavone effects on bone mineral content (BMC) and bone mineral density (BMD) in young adult women
37. Effects of soy protein on bone metabolism
38. Soy protein with its isoflavones improves bone markers in middle-aged and elderly women
39. Dietary soy protein prevents bone loss in an ovariectomized rat model of osteoporosis
40. Bone-sparing effect of soy protein in ovarian hormone deficiency is related to its isoflavone content
41. The role of soy protein with normal or reduced isoflavone content in reversing ovarian hormone deficiency induced bone loss in rats
42. Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomized rat
43. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats
44. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model
45. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats
46. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats
47. Evaluation of effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis
48. Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells
49. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures
50. Effect of estrogen deficiency on IGF-I plasma levels: Relationship with bone mineral density in premenopausal women
51. Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: Relationship with bone mineral density and lipid metabolism in perimenopausal women
52. Relationship between baseline IGF-I and femoral bone density in women aged over 70 years: Potential implications for prevention of age-related bone loss
53. Soy intake and risk of breast cancer in Asians and Asian Americans
54. Comparative epidemiology of cancer between the United States and Japan: A second look
55. Soy for breast cancer survivors: A critical review of the literature
56. Dietary estrogens - A probable cause of infertility in liver disease in captive cheetahs
57. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats
58. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques
59. Effects of soy protein supplementation on epithelial proliferation in the histologically normal human breast
60. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women